Press Releases
TRIAGENICS ADDS 20th INTERNATIONAL PATENT TO ITS MEDICAL DEVICE PORTFOLIO
U.S. based oral health company further strengthens its global intellectual property position for novel 3rd molar tooth bud ablation (3TBA) technology.
February 18, 2025
TRIAGENICS COMPLETES $5 MILLION SERIES A-3 RAISE
Investors rally around the company’s latest funding round for Zero3® TBA, a novel 3rd molar tooth bud ablation treatment and patented technology.
January 10, 2025
TRIAGENICS DEVELOPING SURGERY-FREE TREATMENT TO PREVENT WISDOM TEETH FORMATION
Latest research demonstrates success using high-precision, CT-guided tumor treatment to stop development of troublesome wisdom teeth.
September 12, 2023
TRIAGENICS DEVELOPING SURGERY-FREE WISDOM TOOTH BUD ABLATION TREATMENT
Latest Research Demonstrates Success Using High-Precision CT-Guided Tumor Treatment to Prevent Wisdom Tooth Formation
June 30, 2023
KEY PATENT ISSUED FOR NEW DENTAL ABLATION TECHNOLOGY
The U.S. Patent Office recently issued a patent for a novel 3rd molar tooth budablation technology to TriAgenics, Inc.
April 25, 2023